Main Article Content
Introduction: The critical condition known as "acute heart failure (AHF)” needs to be managed as quickly as possible with the most appropriate medication. Furosemide and nitroglycerin are both typical medications that are utilised in the treatment of AHF. In the treatment of AHF the purpose of this observational study is to evaluate how safe and effective these two medications are.
Methods: The data from patients who were hospitalised to current hospital with a diagnosis of AHF and treated with either furosemide or nitroglycerin were examined via the lens of retrospective research. The incidence of adverse events, such as low blood pressure, irregular heartbeats, and renal failure, served as the key measure of success. Alterations in vital signs, the length of time spent in the hospital, and mortality were included as secondary outcomes.
Results: The results showed that a total of 200 patients took part in the trial, 100 of whom were divided among the three groups. When compared to the group that received furosemide (15%), the rate of adverse events was significantly higher in the nitroglycerin group (25%) (p = 0.05). Additionally, the nitroglycerin group had a significantly higher incidence of hypotension (p = 0.01) and arrhythmia (p = 0.04). However, when it came to renal dysfunction, changes in vital signs, length of hospital stay, or mortality rate, there were no statistically significant differences between the two groups.
Conclusion: In the treatment of AHF the results of this study imply that furosemide may be a more secure option to nitroglycerin. However, additional research is required to substantiate these findings and establish the appropriate dosage and treatment duration for furosemide in AHF patients
WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240-e327. doi:10.1161/CIR.0b013e31829e8776
Butler J, Fonarow GC, Zile MR, Lam CS, Roessig L, Schelbert EB, et al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014;2(2):97-112.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(27):2129-200.
Heaney JLJ, Phillips AC, Carroll D. Ageing, depression, anxiety, social support and the diurnal rhythm and awakening response of salivary cortisol. Int J Psychophysiol. 2010;78(3):201-8.
Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail. 2015;17(12):1262-70.
den Uil CA, Brugts JJ. Impact of intravenous nitroglycerin in the management of acute decompensated heart failure. Curr Heart Fail Rep. 2015;12(1):87-93. doi:10.1007/s11897-014-0230-8.
Maleki A, Sadeghi M, Zaman M, Tarrahi MJ, Nabatchi B. Nifedipine, Captopril or Sublingual Nitroglycerin, Which can Reduce Blood Pressure the Most?. ARYA Atheroscler. 2011;7(3):102-105..
Mielniczuk LM, Tsang SW, Desai AS, Nohria A, Lewis EF, Fang JC, et al. The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients. J Card Fail. 2008;14(6):497-503.
Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985;55(9):1037-42.
McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365(9474):1877-89.
Angeli P, Chiesa M, Caregaro L, et al. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med. 1991;151(4):678-682.
Alzahri MS, Rohra A, Peacock WF. Nitrates as a Treatment of Acute Heart Failure. Card Fail Rev. 2016;2(1):51-55. doi:10.15420/cfr.2016:3:3